• Perospirone (SM-9018 Freebase): Advanced Use in Schizophreni

  2026-05-19

  Perospirone (SM-9018 freebase) enables researchers to dissect serotonergic, dopaminergic, and vascular pathways in schizophrenia and cardiovascular models with precision. Its proven dual action—classic receptor antagonism and selective Kv1.5 channel inhibition—offers an experimental edge for both neuropsychiatric and vascular pharmacology studies.

• Lamotrigine: High-Purity Sodium Channel Blocker for CNS Rese

  2026-05-18

  Lamotrigine, chemically 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, is a rigorously characterized anticonvulsant compound used in neurological and cardiac research. It acts as a sodium channel blocker and serotonin pathway inhibitor, with well-documented IC50 values and exceptional purity. This article details its mechanistic rationale, validated benchmarks, and integration in state-of-the-art blood-brain barrier models.

• CUDC-907: Practical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-18

  CUDC-907 addresses the need for precise, dual inhibition of PI3K and HDAC pathways in cancer cell research, particularly in studies requiring simultaneous modulation of PI3K/AKT signaling and histone acetylation. This compound is designed specifically for controlled in vitro workflows, not for diagnostic or medical uses.

• Magnetic Stimulation Modulates GABAA ε Subunit in Schizophre

  2026-05-17

  This study demonstrates that targeted magnetic stimulation of the prelimbic cortex downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits in mouse models. The findings clarify the neural mechanisms of noninvasive brain stimulation and identify Gabre as a promising molecular target for future schizophrenia research.

• Escitalopram: Optimizing Antidepressant Research Workflows

  2026-05-16

  Escitalopram stands out as a highly selective serotonin reuptake inhibitor, enabling precision in antidepressant and anxiolytic activity studies. Learn how to leverage APExBIO's Escitalopram for robust, reproducible serotonergic pathway research—and avoid common pitfalls with expert troubleshooting tips.

• Magnetic Stimulation Downregulates GABAA ε in Schizophrenia

  2026-05-15

  This study demonstrates that targeted magnetic stimulation of the left prelimbic cortex selectively downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits in murine models. The findings define a mechanistic pathway for neuromodulation-based intervention and highlight molecular targets for advanced schizophrenia research.

• Deep Learning Enhances Cardiotoxicity Detection in iPSC-CMs

  2026-05-15

  Grafton et al. demonstrate a scalable deep learning workflow for early detection of drug-induced cardiotoxicity using iPSC-derived cardiomyocytes and high-content screening. This approach increases assay sensitivity and supports safer drug development by identifying cardiotoxic liabilities earlier in the discovery pipeline.

• Biotin-tyramide: Precision Signal Amplification for IHC & IS

  2026-05-14

  Biotin-tyramide is an advanced biotinylation reagent that enables ultrasensitive, enzyme-mediated signal amplification in immunohistochemistry (IHC) and in situ hybridization (ISH). Its mechanism leverages horseradish peroxidase (HRP) catalysis for spatially precise protein labeling. The reagent delivers high specificity and is validated for use in proximity labeling and spatial transcriptomics.

• Targeted Delivery of Amikacin into Granulomas via Dendritic

  2026-05-14

  Montes-Worboys et al. demonstrate a targeted approach for delivering amikacin into granulomas formed during Mycobacterium avium infection by using monocyte-derived dendritic cells as cellular vehicles. This strategy achieves high local antibiotic concentrations with minimal systemic exposure, offering a promising adjunct to current therapies and addressing key challenges in the treatment of nontuberculous mycobacterial infections.

• Azathramycin A: Structural Insights and Biophysical Decision

  2026-05-13

  Explore the scientific foundation of Azathramycin A as a macrolide antibiotic, with an emphasis on structural-functional insights and biophysical screening considerations for tuberculosis research. This article uniquely connects chemical stability, degradation pathways, and optimal experimental design.

• Cimetidine in Translational Assays: Distinct H2R Modulation

  2026-05-13

  Explore Cimetidine as a histamine-2 receptor antagonist with a unique partial agonist profile, highlighting its advanced applications in translational research—from gastrointestinal cancer to cutting-edge blood-brain barrier models. This article delivers in-depth protocol guidance, scientific insights, and strategic positioning beyond existing content.

• Fe3O4@ZIF-8 Nanoparticles: Antibacterial and Osteogenic Acti

  2026-05-12

  This study demonstrates that Fe3O4@ZIF-8 core–shell nanoparticles can simultaneously combat infection and promote bone regeneration in jaw osteomyelitis. By leveraging pH-responsive Zn2+ release and magnetic field synergy, the platform offers a dual-function nanomaterial approach with translational potential for chronic bone infection therapy.

• 5-HT3 Antagonists Inhibit Renal OCT2 and MATE1: In Vitro Evi

  2026-05-12

  This study rigorously investigates the in vitro inhibition of renal OCT2 and MATE1 transporters by five clinically relevant 5-HT3 receptor antagonists, notably including palonosetron hydrochloride. The findings provide key quantitative insight into drug–transporter interactions, informing both experimental design and clinical considerations in antiemetic therapy for cancer patients.

• Vascular Effects of JAK Inhibitors in Endothelial Inflammati

  2026-05-11

  This study systematically compared the vascular effects of different JAK inhibitors, including tofacitinib citrate, on human endothelial cells exposed to pro-inflammatory cytokines. It reveals both common anti-inflammatory actions and distinct profiles regarding endothelial dysfunction and coagulation, informing the design and interpretation of immune regulation and cardiovascular risk research.

• Thiothixene Stimulates Macrophage Efferocytosis via Arginase

  2026-05-11

  The referenced study demonstrates that thiothixene, a typical antipsychotic agent, robustly enhances efferocytosis and continual clearance of apoptotic and lipid-laden cells by macrophages via induction of Stra6l and Arginase 1. These findings connect dopamine signaling modulation to immune clearance mechanisms, offering translational potential for chronic inflammatory conditions.

15726 records 3/1049 page Previous Next 12345 下5页 Last page